-
Penn study proves promising for type 1 diabetes cure
After a promising study by Penn researchers, a cure for type 1 diabetes appears to be closer to reality. A research team led by Penn scientists successfully transplanted insulin-producing cells into multiple animal models, PhillyVoice reported. In type 1 diabetes, beta cells in clusters called islets cannot regulate blood sugar…
-
Major advancement in islet cell transplantation for treating Type-1 diabetes
A cure for Type-1 diabetes has come closer with the development of a new method for keeping transplanted insulin-producing cells alive and functional in recipients for long periods even when transplanted underneath the skin. A team led by researchers at the Perelman School of Medicine reports the new method, and…
-
Breakthrough Research Cures Diabetes Type 1 Using Stem Cells
New research, which was led by the assistant professor of medicine and biomedical engineering at Washington University School of Medicine in St. Louis, Jeffrey R. Millman, has recently shown the potential of stem cells in the treatment of type 1 diabetes. More specifically, the researchers looked at how stem cells…
-
First-of-its-Kind Bio-Artificial Pancreas on Track for Type-I Diabetes Cure
Leading biomedical company Beta-O2 Technologies gearing up to start second round of human clinical trials within the year on heels of promising preliminary results Boston, MA — Imagine a world where those living with Type 1 Diabetes, a chronic illness affecting more than 60 million adults globally, no longer had…
-
Vertex’s $950 Million Bet That Could Pay Off Big-Time for Investors
If you’re familiar with Vertex Pharmaceuticals (NASDAQ:VRTX), probably the first thing that comes to mind when you think about the big biotech is cystic fibrosis (CF). That’s understandable, considering Vertex’s tremendous success so far has been due to its CF franchise. However, Vertex is also working to expand its horizons…
-
Manufacturing Novel Stem Cell Products To Treat Type 1 Diabetes
The ISLET project, a multi-center collaboration of leading European researchers, aims to develop a manufacturing pipeline for stem cell-based products to treat patients with Type 1 Diabetes. In Type 1 Diabetes a patient’s immune system destroys the beta cells within the islets of Langerhans in the pancreas making a patient…
-
Cancer drug neratinib offers hope for type 1 diabetes treatment
A drug used to treat breast cancer, neratinib, has the potential to halt the immune system from destroying beta cells in type 1 diabetes, according to German researchers. Neratinib was able to guard the beta cells, which produce insulin in the pancreas, from attack. The JDRF-funded study showed that the…
-
Happy 2019 World Diabetes Day – November 14th 2019
We wish everyone a happy World Diabetes Day. We wish we didn’t have to celebrate this, but since we are, let’s all have some cake, bolus a little and make the best of it! Here’s hoping to more accessible treatments, a cure, and most of all, GOOD HEALTH!
-
Israeli artificial pancreas may one day cure diabetes
Ahead of International Diabetes Day, November 14, Israeli startup Betalin Therapeutics announced that it is beginning the application process for clinical trials of its revolutionary artificial pancreas. Betalin’s Engineered Micro Pancreas (EMP) aims to free patients suffering from the most severe types of diabetes from constantly monitoring blood-sugar levels and…
-
Israeli scientists: Cure for insulin-dependent diabetics within five years
A team of Jerusalem-based researchers and entrepreneurs claim they have a cure for diabetes that could hit the market as early as within the next few years. Betalin Therapeutics has developed the first bio-artificial pancreas, composed of pig’s lung tissue and insulin secreting cells. The artificial pancreas would be implanted…
